Cargando…

A Novel Locally c-di-GMP-Controlled Exopolysaccharide Synthase Required for Bacteriophage N4 Infection of Escherichia coli

A major target of c-di-GMP signaling is the production of biofilm-associated extracellular polymeric substances (EPS), which in Escherichia coli K-12 include amyloid curli fibers, phosphoethanolamine-modified cellulose, and poly-N-acetylglucosamine. However, the characterized c-di-GMP-binding effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Junkermeier, Eike H., Hengge, Regine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669469/
https://www.ncbi.nlm.nih.gov/pubmed/34903052
http://dx.doi.org/10.1128/mbio.03249-21
_version_ 1784614784398786560
author Junkermeier, Eike H.
Hengge, Regine
author_facet Junkermeier, Eike H.
Hengge, Regine
author_sort Junkermeier, Eike H.
collection PubMed
description A major target of c-di-GMP signaling is the production of biofilm-associated extracellular polymeric substances (EPS), which in Escherichia coli K-12 include amyloid curli fibers, phosphoethanolamine-modified cellulose, and poly-N-acetylglucosamine. However, the characterized c-di-GMP-binding effector systems are largely outnumbered by the 12 diguanylate cyclases (DGCs) and 13 phosphodiesterases (PDEs), which synthetize and degrade c-di-GMP, respectively. E. coli possesses a single protein with a potentially c-di-GMP-binding MshEN domain, NfrB, which—together with the outer membrane protein NfrA—is known to serve as a receptor system for phage N4. Here, we show that NfrB not only binds c-di-GMP with high affinity but, as a novel c-di-GMP-controlled glycosyltransferase, synthesizes a secreted EPS, which can impede motility and is required as an initial receptor for phage N4 infection. In addition, a systematic screening of the 12 DGCs of E. coli K-12 revealed that specifically DgcJ is required for the infection with phage N4 and interacts directly with NfrB. This is in line with local signaling models, where specific DGCs and/or PDEs form protein complexes with particular c-di-GMP effector/target systems. Our findings thus provide further evidence that intracellular signaling pathways, which all use the same diffusible second messenger, can act in parallel in a highly specific manner.
format Online
Article
Text
id pubmed-8669469
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-86694692021-12-16 A Novel Locally c-di-GMP-Controlled Exopolysaccharide Synthase Required for Bacteriophage N4 Infection of Escherichia coli Junkermeier, Eike H. Hengge, Regine mBio Research Article A major target of c-di-GMP signaling is the production of biofilm-associated extracellular polymeric substances (EPS), which in Escherichia coli K-12 include amyloid curli fibers, phosphoethanolamine-modified cellulose, and poly-N-acetylglucosamine. However, the characterized c-di-GMP-binding effector systems are largely outnumbered by the 12 diguanylate cyclases (DGCs) and 13 phosphodiesterases (PDEs), which synthetize and degrade c-di-GMP, respectively. E. coli possesses a single protein with a potentially c-di-GMP-binding MshEN domain, NfrB, which—together with the outer membrane protein NfrA—is known to serve as a receptor system for phage N4. Here, we show that NfrB not only binds c-di-GMP with high affinity but, as a novel c-di-GMP-controlled glycosyltransferase, synthesizes a secreted EPS, which can impede motility and is required as an initial receptor for phage N4 infection. In addition, a systematic screening of the 12 DGCs of E. coli K-12 revealed that specifically DgcJ is required for the infection with phage N4 and interacts directly with NfrB. This is in line with local signaling models, where specific DGCs and/or PDEs form protein complexes with particular c-di-GMP effector/target systems. Our findings thus provide further evidence that intracellular signaling pathways, which all use the same diffusible second messenger, can act in parallel in a highly specific manner. American Society for Microbiology 2021-12-14 /pmc/articles/PMC8669469/ /pubmed/34903052 http://dx.doi.org/10.1128/mbio.03249-21 Text en Copyright © 2021 Junkermeier and Hengge. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Junkermeier, Eike H.
Hengge, Regine
A Novel Locally c-di-GMP-Controlled Exopolysaccharide Synthase Required for Bacteriophage N4 Infection of Escherichia coli
title A Novel Locally c-di-GMP-Controlled Exopolysaccharide Synthase Required for Bacteriophage N4 Infection of Escherichia coli
title_full A Novel Locally c-di-GMP-Controlled Exopolysaccharide Synthase Required for Bacteriophage N4 Infection of Escherichia coli
title_fullStr A Novel Locally c-di-GMP-Controlled Exopolysaccharide Synthase Required for Bacteriophage N4 Infection of Escherichia coli
title_full_unstemmed A Novel Locally c-di-GMP-Controlled Exopolysaccharide Synthase Required for Bacteriophage N4 Infection of Escherichia coli
title_short A Novel Locally c-di-GMP-Controlled Exopolysaccharide Synthase Required for Bacteriophage N4 Infection of Escherichia coli
title_sort novel locally c-di-gmp-controlled exopolysaccharide synthase required for bacteriophage n4 infection of escherichia coli
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669469/
https://www.ncbi.nlm.nih.gov/pubmed/34903052
http://dx.doi.org/10.1128/mbio.03249-21
work_keys_str_mv AT junkermeiereikeh anovellocallycdigmpcontrolledexopolysaccharidesynthaserequiredforbacteriophagen4infectionofescherichiacoli
AT henggeregine anovellocallycdigmpcontrolledexopolysaccharidesynthaserequiredforbacteriophagen4infectionofescherichiacoli
AT junkermeiereikeh novellocallycdigmpcontrolledexopolysaccharidesynthaserequiredforbacteriophagen4infectionofescherichiacoli
AT henggeregine novellocallycdigmpcontrolledexopolysaccharidesynthaserequiredforbacteriophagen4infectionofescherichiacoli